AU4841599A - Methods and transdermal compositions for pain relief - Google Patents
Methods and transdermal compositions for pain relief Download PDFInfo
- Publication number
- AU4841599A AU4841599A AU48415/99A AU4841599A AU4841599A AU 4841599 A AU4841599 A AU 4841599A AU 48415/99 A AU48415/99 A AU 48415/99A AU 4841599 A AU4841599 A AU 4841599A AU 4841599 A AU4841599 A AU 4841599A
- Authority
- AU
- Australia
- Prior art keywords
- compound
- transdermal composition
- amine containing
- transdermal
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/106,684 US6290986B1 (en) | 1996-10-24 | 1998-06-29 | Method and composition for transdermal administration of pharmacologic agents |
US09106684 | 1998-06-29 | ||
US12290399P | 1999-03-05 | 1999-03-05 | |
US60122903 | 1999-03-05 | ||
PCT/US1999/014653 WO2000000120A1 (fr) | 1998-06-29 | 1999-06-29 | Compositions antalgiques transdermiques et leurs methodes d'administration |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4841599A true AU4841599A (en) | 2000-01-17 |
Family
ID=26803907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU48415/99A Abandoned AU4841599A (en) | 1998-06-29 | 1999-06-29 | Methods and transdermal compositions for pain relief |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1093348A4 (fr) |
JP (1) | JP2002519310A (fr) |
KR (1) | KR20010078754A (fr) |
CN (1) | CN1331576A (fr) |
AU (1) | AU4841599A (fr) |
BG (1) | BG105175A (fr) |
BR (1) | BR9912508A (fr) |
CA (1) | CA2335837A1 (fr) |
HR (1) | HRP20000905A2 (fr) |
HU (1) | HUP0102728A3 (fr) |
ID (1) | ID28213A (fr) |
IL (1) | IL140420A0 (fr) |
MX (1) | MXPA00012767A (fr) |
NO (1) | NO20006604L (fr) |
PL (1) | PL345216A1 (fr) |
SK (1) | SK20012000A3 (fr) |
TR (1) | TR200003801T2 (fr) |
WO (1) | WO2000000120A1 (fr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6572880B2 (en) * | 1996-10-24 | 2003-06-03 | Pharmaceutical Applications Associates Llc | Methods and transdermal compositions for pain relief |
EP0986540B1 (fr) | 1997-04-22 | 2005-02-16 | Euro-Celtique S.A. | L'utilisation des semicarbazones et thiosemicarbazones carbocycliques et heterocycliques substitues comme agents bloquants du canal sodique |
PL196996B1 (pl) | 1999-07-01 | 2008-02-29 | Upjohn Co | Zastosowanie optycznie czystej (S,S)-reboksetyny lub jej dopuszczalnej farmaceutycznie soli do wytwarzania leku |
DK1500395T3 (da) * | 1999-07-01 | 2006-06-19 | Pharmacia & Upjohn Co Llc | Reboxetin til behandling af fibromyalgi og andre somatoforme lidelser |
WO2001041732A1 (fr) * | 1999-12-06 | 2001-06-14 | Gore Stanley L | Compositions et procedes d'administration intranasale d'agents actifs destines au cerveau |
IN191512B (fr) * | 2000-01-21 | 2003-12-06 | Panacea Biotech | |
DE10032132A1 (de) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung |
DE10042412B4 (de) * | 2000-08-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung |
US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
SI2218448T1 (sl) | 2002-12-13 | 2016-01-29 | Durect Corporation | Sistem za oralno dajanje zdravila, ki obsega tekoči nosilec materialov z visoko viskoznostjo |
JP2005154368A (ja) * | 2003-11-27 | 2005-06-16 | Teikoku Seiyaku Co Ltd | ジソピラミド含有神経因性疼痛の鎮痛剤 |
JP4807721B2 (ja) * | 2004-01-29 | 2011-11-02 | 株式会社 メドレックス | 消炎鎮痛外用剤 |
ES2378671T3 (es) | 2004-09-17 | 2012-04-16 | Durect Corporation | Composición anestésica local prolongada que contiene SAIB |
US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
JP2007308403A (ja) * | 2006-05-17 | 2007-11-29 | Kenji Yoshida | 皮膚外用剤 |
KR100880748B1 (ko) * | 2006-08-29 | 2009-02-02 | 정헌택 | 디메톡시커큐민을 함유하는 혈관재협착 방지용 조성물 |
EP2117521B1 (fr) | 2006-11-03 | 2012-06-27 | Durect Corporation | Systèmes d'administration par voie transdermique |
US9511016B2 (en) * | 2007-06-12 | 2016-12-06 | Epicentrx, Inc. | Topical composition for treating pain |
CA2706931C (fr) | 2007-12-06 | 2015-05-12 | Durect Corporation | Formes posologiques pharmaceutiques orales |
US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
JP5826742B2 (ja) * | 2009-05-07 | 2015-12-02 | ドンコック ファーマシューティカル カンパニー リミテッド | 神経損傷及び神経疾患の予防または治療用薬学組成物 |
US8491927B2 (en) | 2009-12-02 | 2013-07-23 | Nimble Epitech, Llc | Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor |
AU2014233453A1 (en) | 2013-03-15 | 2015-10-01 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
RU2016136430A (ru) * | 2014-02-11 | 2018-03-15 | Др. Редди'С Лабораторис Лтд. | Парентеральные композиции целекоксиба |
EP3870150A1 (fr) | 2018-10-26 | 2021-09-01 | Viramal Limited | Composition de gel mucoadhésif |
ES2948955T3 (es) | 2018-11-30 | 2023-09-22 | Viramal Ltd | Un método de preparación de un agente gelificante, el agente gelificante obtenido de este modo y el uso de dicho agente gelificante |
CA3167217A1 (fr) | 2020-01-13 | 2021-07-22 | Durect Corporation | Systemes d'administration de medicament a liberation prolongee avec impuretes reduites et procedes associes |
FR3108841B1 (fr) * | 2020-04-06 | 2023-11-03 | Algotherapeutix | Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4395420A (en) * | 1981-12-09 | 1983-07-26 | Bernstein Joel E | Method and composition for treating pruritis |
SI9300468A (en) * | 1992-10-14 | 1994-06-30 | Hoffmann La Roche | Injectable composition for the sustained release of biologically active compounds |
GB9315856D0 (en) * | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized pharmaceutical |
US5654337A (en) * | 1995-03-24 | 1997-08-05 | II William Scott Snyder | Topical formulation for local delivery of a pharmaceutically active agent |
US5837289A (en) * | 1996-07-23 | 1998-11-17 | Grasela; John C. | Transdermal delivery of medications using a combination of penetration enhancers |
US5885597A (en) * | 1997-10-01 | 1999-03-23 | Medical Research Industries,Inc. | Topical composition for the relief of pain |
-
1999
- 1999-06-29 WO PCT/US1999/014653 patent/WO2000000120A1/fr not_active Application Discontinuation
- 1999-06-29 MX MXPA00012767A patent/MXPA00012767A/es unknown
- 1999-06-29 PL PL99345216A patent/PL345216A1/xx unknown
- 1999-06-29 BR BR9912508-0A patent/BR9912508A/pt not_active Application Discontinuation
- 1999-06-29 CA CA002335837A patent/CA2335837A1/fr not_active Abandoned
- 1999-06-29 SK SK2001-2000A patent/SK20012000A3/sk unknown
- 1999-06-29 IL IL14042099A patent/IL140420A0/xx unknown
- 1999-06-29 TR TR2000/03801T patent/TR200003801T2/xx unknown
- 1999-06-29 ID IDW20010231A patent/ID28213A/id unknown
- 1999-06-29 AU AU48415/99A patent/AU4841599A/en not_active Abandoned
- 1999-06-29 EP EP99932017A patent/EP1093348A4/fr not_active Withdrawn
- 1999-06-29 HU HU0102728A patent/HUP0102728A3/hu unknown
- 1999-06-29 CN CN99810055A patent/CN1331576A/zh active Pending
- 1999-06-29 JP JP2000556706A patent/JP2002519310A/ja active Pending
- 1999-06-29 KR KR1020007014985A patent/KR20010078754A/ko not_active Application Discontinuation
-
2000
- 2000-12-22 NO NO20006604A patent/NO20006604L/no not_active Application Discontinuation
- 2000-12-28 HR HR20000905A patent/HRP20000905A2/hr not_active Application Discontinuation
-
2001
- 2001-01-24 BG BG105175A patent/BG105175A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
SK20012000A3 (sk) | 2001-08-06 |
CN1331576A (zh) | 2002-01-16 |
KR20010078754A (ko) | 2001-08-21 |
HUP0102728A2 (hu) | 2002-03-28 |
WO2000000120A1 (fr) | 2000-01-06 |
CA2335837A1 (fr) | 2000-01-06 |
PL345216A1 (en) | 2001-12-03 |
EP1093348A1 (fr) | 2001-04-25 |
BR9912508A (pt) | 2001-05-02 |
NO20006604D0 (no) | 2000-12-22 |
HUP0102728A3 (en) | 2002-12-28 |
IL140420A0 (en) | 2002-02-10 |
WO2000000120A9 (fr) | 2000-03-30 |
EP1093348A4 (fr) | 2003-07-16 |
MXPA00012767A (es) | 2002-08-09 |
TR200003801T2 (tr) | 2001-06-21 |
HRP20000905A2 (en) | 2001-08-31 |
NO20006604L (no) | 2001-02-28 |
BG105175A (bg) | 2001-11-30 |
ID28213A (id) | 2001-05-10 |
JP2002519310A (ja) | 2002-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6572880B2 (en) | Methods and transdermal compositions for pain relief | |
US6479074B2 (en) | Methods and transdermal compositions for pain relief | |
US20020015713A1 (en) | Methods and transdermal compositions for pain relief | |
AU4841599A (en) | Methods and transdermal compositions for pain relief | |
US6290986B1 (en) | Method and composition for transdermal administration of pharmacologic agents | |
JP4901042B2 (ja) | クロニジン製剤 | |
US8652491B2 (en) | Transdermal compositions for anticholinergic agents | |
US8883830B2 (en) | Topical therapy for the treatment of migraines, muscle sprains, muscle spasms, spasticity and related conditions | |
EP1435945B1 (fr) | Therapie antimigraineuse par voie topique | |
EP2073819B1 (fr) | Formulations topiques contenant le co-enzyme q10 et traitement de la fatigue, de la douleur et des plaies | |
US9012480B2 (en) | Topical therapy for migraine | |
JP2020500915A (ja) | 末梢神経障害性疼痛の治療に使用するための局所作用用フェニトイン | |
WO1999011208A1 (fr) | Methode et composition permettant l'administration transdermique d'agents pharmacologiques | |
US20030054030A1 (en) | Method and compositions for the treatment of pruritus | |
KR100347883B1 (ko) | 국소마취제를 함유한 약용겔제 조성물 | |
CZ20004823A3 (cs) | Způsoby a transdermální prostředky pro zmírnění bolesti | |
MXPA05010939A (en) | Alcohol-free transdermal analgesic composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |